National Oilwell Varco
NOV
$20.22
+2.28%
NOV Inc. is a leading global provider of equipment and components for the oil and gas industry, designing and manufacturing rig equipment, downhole tools, drill pipe, and well casing. The company operates as a major integrated supplier with a significant international footprint, serving a diverse customer base that includes major integrated oil companies, national oil companies, and drilling contractors. The current investor narrative is focused on the company's ability to navigate the volatile energy cycle, with recent attention on its substantial 20% dividend increase signaling management's confidence in sustained cash flow generation, while debates center on the sustainability of its recent financial performance amidst fluctuating oil prices and capital expenditure trends in the energy sector.…
NOV
National Oilwell Varco
$20.22
Related headlines
Investment Opinion: Should I buy NOV Today?
Rating & Thesis: Hold. NOV presents a classic 'value with questions' case—its deep discount to history and strong cash flow are compelling, but these are counterbalanced by near-term operational volatility and a lack of clear earnings momentum, warranting a neutral stance pending clearer fundamental improvement. This aligns with the mixed but leaning neutral analyst sentiment.
Supporting Evidence: The primary valuation metric, the PS ratio of 0.66, represents a deep discount to the stock's own multi-year history. The forward P/E of 15.07, applied to the consensus EPS of $1.88, implies a price target ~48% above the current level, suggesting embedded upside. Financially, the company's robust TTM free cash flow of $876M and a debt-to-equity ratio of 0.37 provide a solid foundation. However, the recent Q4 revenue decline of 1.34% and net loss underscore the growth and profitability challenges.
Risks & Conditions: The two biggest risks are a failure to stabilize earnings (evidenced by the Q4 net loss) and a downturn in the energy capex cycle compressing the already-low valuation multiples. This Hold rating would upgrade to a Buy if the company delivers consecutive quarters of positive net income with stable or expanding margins, confirming an earnings recovery. It would downgrade to a Sell if revenue growth turns meaningfully negative (e.g., below -5% YoY) or free cash flow generation deteriorates significantly. Relative to its history, the stock is deeply undervalued, but relative to its current earnings power, it appears fairly-to-overvalued, creating a stalemate that favors a wait-and-see approach.
Sign up to view all
NOV 12-Month Price Forecast
NOV is a financially strong company trapped in a volatile sector cycle, resulting in a stalemate between its attractive valuation/cash flow and its lackluster near-term earnings momentum. The neutral stance reflects this balance: the downside appears somewhat protected by the balance sheet and valuation floor, but the upside is contingent on an earnings recovery that has yet to materialize consistently. Confidence is medium due to the high quality of the balance sheet data but low visibility on earnings. The stance would upgrade to bullish on evidence of two consecutive quarters of margin-stable net income growth. It would downgrade to bearish on a breakdown below key technical support near $18 or a significant deterioration in quarterly free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on National Oilwell Varco's 12-month outlook, with a consensus price target around $26.29 and implied upside of +30.0% versus the current price.
Average Target
$26.29
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$16 - $26
Analyst target range
Analyst coverage is limited with only 6 analysts providing estimates, and the institutional ratings show a mixed but leaning neutral sentiment, with recent actions including a 'Sell' from Goldman Sachs, 'Neutral' from Citigroup and Piper Sandler, 'Market Perform' from BMO Capital, and 'Buy' from Stifel and TD Cowen. The consensus revenue estimate for the next period is $9.525 billion with a range from $9.24 billion to $9.79 billion, and the EPS estimate is $1.88 with a range from $1.81 to $1.95; the wide target spread, particularly on revenue, signals high uncertainty among analysts regarding the company's near-term financial performance, which is typical for a cyclical stock exposed to volatile energy prices and capex decisions.
Bulls vs Bears: NOV Investment Factors
The investment debate for NOV centers on a powerful clash between its deep-value valuation and strong cash generation versus its inconsistent operational performance and cyclical headwinds. The bull case is anchored in a historically cheap PS ratio of 0.66, robust $876M TTM free cash flow, and a fortress balance sheet that supports a 20% dividend hike. The bear case highlights volatile earnings, a recent quarterly net loss, and plateauing revenue that challenge near-term growth. Currently, the bull side has stronger evidence due to the compelling valuation discount and tangible financial strength, but the thesis is highly contingent on the resolution of a single critical tension: whether management can translate its strong cash flow and balance sheet into sustained earnings growth, or if operational volatility will keep the stock trapped in a value trap cycle. The upcoming quarters' ability to stabilize margins and return to profit will be the decisive factor.
Bullish
- Strong Cash Flow & Dividend Hike: NOV generated $876 million in TTM free cash flow and announced a 20% dividend increase in February 2026. This signals management's confidence in sustained cash generation and capital return capability, even amidst earnings volatility.
- Deep Discount to Historical Valuation: The stock trades at a PS ratio of 0.66, which is near the bottom of its multi-year range and far below historical levels above 2.0. This deep discount to its own history presents a potential value opportunity if the business cycle stabilizes.
- Robust Balance Sheet & Liquidity: The company maintains a strong current ratio of 2.42 and a low debt-to-equity ratio of 0.37. This financial fortress provides resilience against cyclical downturns and funds shareholder returns without excessive leverage.
- Sustained Technical Uptrend: The stock has gained 52.43% over the past year and 50.87% over six months, trading at 91.5% of its 52-week range. This powerful momentum, coupled with a beta of 0.94, suggests the uptrend has been driven by company-specific factors with lower systematic risk.
Bearish
- Inconsistent & Declining Revenue: Q4 2025 revenue of $2.277B declined 1.34% YoY, and quarterly revenue has plateaued after peaking in Q4 2024. This indicates a maturing recovery cycle and raises questions about top-line growth sustainability.
- Volatile & Negative Profitability: The company swung to a Q4 2025 net loss of $78 million (net margin -3.4%) from a profit in Q3, and gross margin compressed to 20.29% from 21.36% a year ago. This earnings volatility and margin pressure highlight operational challenges.
- Mixed & Cautious Analyst Sentiment: Analyst ratings are mixed with a 'Sell' from Goldman Sachs and several 'Neutral' or 'Market Perform' ratings. The wide revenue estimate range ($9.24B to $9.79B) reflects high uncertainty about near-term performance in a volatile sector.
- High Valuation on Trailing Earnings: The trailing P/E ratio is an elevated 40.1, driven by depressed recent earnings. This high multiple makes the stock vulnerable to multiple compression if earnings do not recover sharply to justify it.
NOV Technical Analysis
The stock is in a sustained uptrend, evidenced by a 52.43% gain over the past year, and is currently trading at approximately 91.5% of its 52-week range ($19.10 vs. a high of $20.86 and low of $11.44), positioning it near its highs which suggests strong momentum but also potential for near-term overextension. Recent momentum shows a deceleration from the longer-term trend, with a 4.66% gain over the past month and a 6.11% gain over the past three months, indicating a consolidation phase after the powerful 50.87% six-month surge; this divergence could signal a healthy pause for the stock to digest its gains before attempting another leg higher. Key technical support is anchored at the 52-week low of $11.44, while immediate resistance sits at the 52-week high of $20.86; a decisive breakout above $20.86 would confirm the resumption of the primary uptrend, while the stock's beta of 0.94 indicates its volatility is slightly less than the broader market, which is notable for a cyclical energy equipment name and suggests relatively lower systematic risk for position sizing.
Beta
0.94
0.94x market volatility
Max Drawdown
-28.1%
Largest decline past year
52-Week Range
$11-$21
Price range past year
Annual Return
+68.4%
Cumulative gain past year
| Period | NOV Return | S&P 500 |
|---|---|---|
| 1m | +3.6% | +8.5% |
| 3m | +10.0% | +2.8% |
| 6m | +46.1% | +4.6% |
| 1y | +68.4% | +32.3% |
| ytd | +23.2% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOV Fundamental Analysis
Revenue growth has been inconsistent, with the most recent Q4 2025 revenue of $2.277 billion representing a 1.34% year-over-year decline, and the quarterly trend shows revenue peaked in Q4 2024 at $2.308 billion before dipping, indicating a potential plateau in the top-line recovery as the energy cycle matures. Profitability is volatile, with the company posting a net loss of $78 million in Q4 2025 (net margin of -3.4%) following a net income of $42 million in Q3 2025, while the gross margin of 20.29% in Q4 2025 is stable but down from the 21.36% reported in Q4 2024, reflecting margin pressure despite an operating income of $162 million in the latest quarter. The balance sheet is healthy with a strong current ratio of 2.42 and a manageable debt-to-equity ratio of 0.37, and the company generates robust cash flow, evidenced by trailing twelve-month free cash flow of $876 million and operating cash flow of $573 million in Q4 2025, providing ample liquidity to fund operations, the increased dividend, and share repurchases without reliance on excessive external financing.
Quarterly Revenue
$2.3B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
+0.20%
Latest Quarter
Free Cash Flow
$876000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOV Overvalued?
Given the inconsistent profitability with a recent quarterly net loss, the Price-to-Sales (PS) ratio is the most appropriate primary valuation metric. The trailing PS ratio is 0.66, and while a forward PS is not explicitly provided, the estimated revenue for the next period is $9.525 billion, which at the current market cap implies a forward PS of approximately 0.61, suggesting the market expects modest sales growth and potential margin improvement. Compared to industry averages, NOV's valuation appears discounted; for instance, its EV/EBITDA of 8.07 is likely below many oil services peers, and its PS ratio of 0.66 is significantly lower than historical software or high-growth industrial multiples, a discount that may reflect the cyclicality and capital intensity of its core business. Historically, the stock's current PS ratio of 0.66 is near the bottom of its own multi-year range, as historical data shows PS ratios frequently above 2.0 in recent years (e.g., 2.50 in Q4 2025, 2.86 in Q3 2024); this suggests the stock is trading at a deep discount to its own history, which could indicate a value opportunity if fundamentals stabilize, but also may reflect a market pricing in a more pessimistic outlook for the oilfield equipment cycle.
PE
40.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -55x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: NOV faces significant earnings volatility, as evidenced by its swing from a $42M profit in Q3 2025 to a $78M loss in Q4 2025. Gross margin pressure is a concern, declining 107 basis points year-over-year to 20.29%. While the balance sheet is strong, the company's revenue has plateaued, with Q4 showing a 1.34% YoY decline, indicating dependence on a stabilizing or growing energy capex cycle to re-accelerate top-line growth and improve inconsistent profitability.
Market & Competitive Risks: The stock trades at a significant discount to its own historical valuation (PS of 0.66 vs. historical levels above 2.0), but this discount reflects market skepticism about the sustainability of the oilfield equipment cycle. With a beta of 0.94, NOV is not immune to broader market downturns. The primary risk is valuation compression if the energy cycle rolls over before earnings recover, as the elevated trailing P/E of 40.1 is not supported by current earnings power, leaving the stock exposed to derating.
Worst-Case Scenario: The most damaging scenario involves a sharp downturn in oil prices leading to deferred or canceled customer capex, causing NOV's revenue to decline more sharply and margins to compress further. This could trigger analyst downgrades and a flight from cyclical names. In this adverse scenario, the stock could realistically re-test its 52-week low of $11.44, representing a downside of approximately -40% from the current price of $19.10. The historical max drawdown of -28.14% provides a benchmark for the volatility inherent in the name during sector downturns.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Earnings volatility and margin pressure, as seen in the Q4 2025 net loss of $78M and gross margin decline. 2) Cyclical/Market Risk: The stock's fate is tied to oil prices and energy capex; a downturn could compress its already-low valuation multiples. 3) Execution Risk: The company must convert its strong cash flow and balance sheet (D/E 0.37) into consistent profit growth to justify a re-rating. 4) Sentiment Risk: Mixed analyst ratings and a high short ratio of 4.99 reflect skeptical market sentiment that could limit near-term upside.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $19 and $23, as the company delivers modest earnings in line with the $1.88 EPS consensus amid a slow sector recovery. The Bull Case (25% probability) targets $24 to $28, driven by a successful earnings recovery and valuation re-rating. The Bear Case (15% probability) warns of a drop to $11.50-$16 if the energy cycle deteriorates. The Base Case is most likely, predicated on the assumption that NOV's financial strength prevents a deep decline, but operational inconsistency prevents a major breakout.
NOV is deeply undervalued relative to its own multi-year trading history, with a Price-to-Sales ratio of 0.66 compared to historical levels frequently above 2.0. However, relative to its current depressed earnings, the trailing P/E of 40.1 appears stretched, suggesting the market is not yet convinced of a durable earnings recovery. Compared to sector peers, its EV/EBITDA of 8.07 is likely reasonable or discounted. The valuation implies the market is pricing in a stagnant or declining business cycle, offering a potential margin of safety if operations improve.
NOV is a good buy for a specific type of investor: a patient value investor comfortable with cyclical energy sector volatility. The stock trades at a deep discount to its own history (PS ratio 0.66) and boasts a strong balance sheet with $876M in TTM free cash flow. However, it is not a good buy for those seeking stable growth or low risk, given its recent quarterly net loss and inconsistent revenue. The potential upside to the analyst-implied target is significant (~48%), but realizing it requires a recovery in earnings that has yet to be consistently demonstrated.
NOV is more suitable for a long-term investment horizon (2+ years) rather than short-term trading. As a cyclical value stock, realizing its full potential requires time for the business cycle to improve and for the market to recognize the value in its financials. Its beta of 0.94 suggests moderate volatility, but its dependence on energy capex cycles means short-term price movements can be unpredictable. The lack of a high, stable dividend (yield is 3.3%) further reduces its appeal for short-term income strategies. Investors should be prepared to hold through sector volatility to capture the mean reversion thesis.